A Randomized, Open-Label, Active Controlled, Safety and Descriptive Efficacy Study in Pediatric Subjects Requiring Anticoagulation for the Treatment of a Venous Thromboembolic Event
A Randomized, Open-Label, Active Controlled, Safety and Descriptive Efficacy Study in Pediatric Subjects Requiring Anticoagulation for the Treatment of a Venous Thromboembolic Event
To assess the safety and descriptive efficacy of apixaban in pediatric subjects requiring anticoagulation for the treatment of a VTE.
Inclusion Criteria:
Exclusion Criteria:
Sacramento, California 95817, United States
West Palm Beach, Florida 33407, United States
Atlanta, Georgia 30329, United States
Atlanta, Georgia 30329, United States
Charleston, South Carolina 29425, United States
Charleston, South Carolina 29425, United States
Guadalajara, Jalisco 44280, Mexico
Kazan', Republic Tatarstan 420138, Russia
Yekaterinburg, Sverdlovsk Oblast 620149, Russia
Bahçelievler, Ankara 06490, Turkey (Türkiye)
Ankara, 06230, Turkey (Türkiye)
Izmir, 35100, Turkey (Türkiye)
Dnipro, 49006, Ukraine
Zaporizhzhya, 69063, Ukraine
Newcastle upon Tyne, TYNE & WEAR NE1 4LP, United Kingdom